Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Slide-Deoxyribonucleic Acid (DNA)-Sequencing For Copy Number Mapping Market CAGR Outlook And Future Development
The slide-deoxyribonucleic acid (DNA)-sequencing for copy number mapping market size has seen swift expansion in recent years. It is anticipated to increase from $0.38 billion in 2025 to $0.43 billion in 2026, showing a compound annual growth rate (CAGR) of 14.6%. The market’s growth during the historical period is linked to improvements in fluorescent labeling techniques, the implementation of optical mapping sequencing, a rise in cancer genomics research, an increase in genetic disease studies, and the development of academic genomics infrastructure.
The slide-deoxyribonucleic acid (DNA)-sequencing for copy number mapping market size is projected for substantial expansion over the upcoming years, with an anticipated rise to $0.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.8%. This expansion during the forecast period is fueled by elements such as the incorporation of AI-driven variant calling, a heightened need for high-throughput imaging, the embrace of single-molecule sequencing, the proliferation of personalized medicine applications, and the increasing presence of genomic laboratories in developing markets. Key developments anticipated in this period encompass high-resolution DNA mapping, the integration of single-cell sequencing, automated slide processing, spatial genomics analytics, and the modeling of predictive genomic variation.
Get A Free Sample Report With In-Depth Market Insights:
Slide-Deoxyribonucleic Acid (DNA)-Sequencing For Copy Number Mapping Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing need for precision medicine is anticipated to fuel the expansion of the slide-deoxyribonucleic acid (DNA)-sequencing for copy number mapping market in the future. Precision medicine, a healthcare method, utilizes an individual’s unique genetic and molecular attributes to inform diagnosis and treatment choices, leading to better clinical results. The rising global prevalence of intricate and long-term diseases, which necessitate highly specific and tailored treatment strategies, is contributing to the greater adoption of precision medicine. Slide-deoxyribonucleic acid (DNA) sequencing for copy number mapping supports this rising demand by allowing comprehensive analysis of genomic variations, which in turn guides patient-specific diagnosis and therapy. This technology aids in targeted therapies, improves risk evaluation, and refines clinical decisions for more individualized and effective healthcare. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based educational and advocacy organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, a notable increase from 6 in 2022. Consequently, the expanding demand for precision medicine is propelling the growth of the slide-deoxyribonucleic acid (DNA)-sequencing for copy number mapping market.
Slide-Deoxyribonucleic Acid (DNA)-Sequencing For Copy Number Mapping Market Breakdown By Product Type And Application
The slide-deoxyribonucleic acid (DNA)-sequencing for copy number mapping market covered in this report is segmented –
1) By Workflow: Sample Preparation, Sequencing And Imaging, Data Analysis And Interpretation
2) By Product Type: Instruments, Consumables, Software, Services
3) By Sample Type: Fresh Frozen (FF) Tissues, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Organoids And 3D Cell Cultures
4) By Application: Cancer Genomics, Genetic Disease Research, Prenatal Diagnostics, Other Applications
5) By End User: Hospitals And Diagnostic Centers, Academic And Research Institutes, Biotechnology And Pharmaceutical Companies, Contract Research Organizations, Genomic Laboratories
Subsegments:
1) By Sample Preparation: Deoxyribonucleic Acid Extraction, Library Preparation, Fragmentation And Shearing, Quality Control And Quantification
2) By Sequencing And Imaging: Fluorescent Labeling Sequencing, Optical Mapping Sequencing, Single Molecule Sequencing, High Throughput Imaging
3) By Data Analysis And Interpretation: Alignment And Mapping, Variant Calling, Copy Number Variation Analysis, Visualization And Reporting
Slide-Deoxyribonucleic Acid (DNA)-Sequencing For Copy Number Mapping Market Company Landscape And Competitive Strategy
Major companies operating in the slide-deoxyribonucleic acid (DNA)-sequencing for copy number mapping market are Thermo Fisher Scientific, Becton Dickinson Company (BD), Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., 10x Genomics Inc., BGI Genomics Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Fluidigm Corporation, Roche Sequencing Solutions, Mission Bio Inc., Twist Bioscience Corp., Genapsys Inc., Phase Genomics Inc., Singular Genomics Systems Inc.
View The Full Slide-Deoxyribonucleic Acid (DNA)-Sequencing For Copy Number Mapping Market Report:
Slide-Deoxyribonucleic Acid (DNA)-Sequencing For Copy Number Mapping Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the slide-deoxyribonucleic acid (DNA)-sequencing for copy number mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the slide-deoxyribonucleic acid (DNA)-sequencing for copy number mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
